Wells Fargo & Co Upgraded Quest Diagnostics Incorporated ($DGX) to Equal-Weight from Underweight rating; Target Price raised to $ 120.00 up from previous mark of $ 90.00
[redirect url=’https://www.cms.stockmarketintellects.com/company-dashboard/?symbol=DGX’ sec=’1′]
